AMMPS Establishment Declaration Checklist 2026: Form DE RD-IS-PS/04

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The current AMMPS establishment declaration checklist is Form DE RD-IS-PS/04, applicable from 11 May 2026. This is the second checklist changeover within the agency’s transition period, following the ninth version of the registration checklist (Form DE ER DM/01, applicable from 30 January 2025). GRZAN treats the establishment declaration checklist and the registration checklist as two versions that must be tracked in parallel: the former determines whether an establishment can open and submit its declaration, while the latter determines whether a product dossier will be accepted. A mismatch on either list can stall a market-entry project independently of the other, which is why both belong on one controlled version log.

The practical consequence of a checklist changeover is rarely dramatic at the moment it happens, but it accumulates. Declarations filed under a superseded checklist remain valid on their face, yet any supplementary filing triggered by Article 9 must follow the current form. Projects that span a changeover date should therefore map every document already filed against the new list before the next submission, so that gaps surface while there is still time to correct them without delaying a shipment or a product registration.

2. Legal basis

InstrumentReference numberPublication dateProvisions
Medical Devices Law (Loi n° 84-12)Dahir n° 1-13-9030 August 2013Article 7 (declaration dossier set by regulation); Article 8 (90 days); Article 9 (changes)
Ministerial order on establishment declarations for medical devicesArrêté n° 2853-152015Declaration form template, submission method, and dossier composition
AMMPS establishment declaration checklistForm DE RD-IS-PS/04Applicable from 11 May 2026Item-by-item declaration requirements

Practical estimate: the form number and application date come from the checklist currently published by AMMPS. These are operational documents of the competent authority and may be superseded; the current version must be re-checked before any submission.

3. Expert insights

Insight 1: The two checklists change on unsynchronised rhythms, which is a source of risk. The ninth version of the registration checklist applies from 30 January 2025, while the establishment declaration checklist applies from 11 May 2026 — roughly 15 months apart. A company that tracks only one of the two can easily stumble on the other, precisely because the changeovers arrive at different moments of the same project timeline. GRZAN recommends managing both in parallel in the same version log, with an owner assigned to each, so that a single monitoring routine covers both change risks instead of assuming they move together.

Insight 2: The establishment declaration checklist governs who may submit at all, and it operates earlier than the registration checklist. Under Article 12, second paragraph, of Law No. 84-12, only establishments duly declared under Article 7 can obtain registration certificates. The establishment declaration checklist is the concrete expression of that threshold, and it takes effect before the registration checklist ever becomes relevant for a given product. In project terms: if the establishment file is rejected or incomplete under the current checklist, no amount of product dossier quality will move the project forward, because the applicant entity itself is not yet validly in the system.

Insight 3: Version changes usually bring finer-grained documentation requirements. The common direction of checklist revisions is more detailed documentation demands and stricter signing and formatting rules. GRZAN recommends that, once a new checklist applies, companies perform a retrospective review of establishment declaration files completed before the changeover, and assess whether a supplementary declaration is required under Article 9. This review should be documented, because it demonstrates diligence if the authority later questions the currency of an establishment’s file.

Insight 4: The wording of declared activities must match the checklist’s own vocabulary. Article 7 lists four activities: manufacture, import, export, and distribution. Checklists typically organise the declaration by activity type in separate columns, and the activity names used in the declaration must correspond to the checklist wording. Divergent phrasing may not block the initial submission, but it can create ambiguity in later queries and inspections, forcing clarifications that cost time. Copying the checklist’s exact terms into the declaration is a low-effort way to prevent this class of problem.

Insight 5: An establishment’s declaration status can be verified in the AMMPS register. AMMPS publishes a register of declared establishments, searchable by business activity. This is the most direct tool available to a Chinese manufacturer for vetting a candidate partner — it does not depend on the partner’s own statements. Checking the register before signing any cooperation agreement converts an unverifiable claim into documented fact, and the same check should be repeated before certificate transfer discussions begin.

4. Practical recommendations

  1. Maintain a dual-checklist version log. Record the registration checklist (DE ER DM/01) and the establishment declaration checklist (DE RD-IS-PS/04) side by side, with form numbers, version identifiers, and application dates.
  2. Retrospectively review files after a new checklist applies. For establishment declaration files completed before a changeover, assess under Article 9 whether a supplementary declaration is needed.
  3. Vet candidates against the AMMPS register. Verify activity type line by line and confirm coverage of the import or manufacturing activity the project requires.
  4. Align activity wording with the checklist. Ensure that the activity expressions used in declaration files match the checklist’s column terminology exactly.
  5. Write the checklist version into cooperation agreements. Specify which checklist version governs the declaration, and allocate responsibility and costs when a version changes mid-project.

5. Verification checklist

  • □ The current AMMPS establishment declaration checklist (DE RD-IS-PS/04) has been obtained
  • □ The application date (11 May 2026) has been recorded and a changeover review scheduled
  • □ The registration checklist and the establishment declaration checklist are managed in one parallel version log
  • □ Declaration files completed before the changeover have been retrospectively reviewed
  • □ The candidate establishment has been verified against the AMMPS register by activity type
  • □ The activity wording in declaration files matches the checklist terminology
  • □ The cooperation agreement specifies the checklist version and cost allocation on changeover

Regulatory information verified as of 30 October 2026

GRZAN supports medical device manufacturers entering the Moroccan market with checklist version management, establishment declaration files, partner verification against the AMMPS register, and cost budgeting for registration and maintenance obligations. For support on the requirements described above, contact info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail